UC-San Diego Researchers Tapped To Join $41M Research Program To Study Autoimmune Diseases
UC-San Diego has been named to a $41.6 million program, called Accelerating Medicines Partnership, to research treatments for autoimmune diseases, such as rheumatoid arthritis and lupus erythematosus. UC-San Diego researchers will leverage their expertise in genomics and epigenomics to collect and analyze blood and tissue samples from individuals with rheumatoid arthritis.
- "UCSD Named to Autoimmune Disease Project" (Fikes, U-T San Diego, 9/25).